Literature DB >> 11834502

Relation of effective arterial elastance to arterial system properties.

Patrick Segers1, Nikos Stergiopulos, Nico Westerhof.   

Abstract

Effective arterial elastance (E(a)), defined as the ratio of left ventricular (LV) end-systolic pressure and stroke volume, lumps the steady and pulsatile components of the arterial load in a concise way. Combined with E(max), the slope of the LV end-systolic pressure-volume relation, E(a)/E(max) has been used to assess heart-arterial coupling. A mathematical heart-arterial interaction model was used to study the effects of changes in peripheral resistance (R; 0.6-1.8 mmHg x ml(-1) x s) and total arterial compliance (C; 0.5-2.0 ml/mmHg) covering the human pathophysiological range. E(a), E(a)/E(max,) LV stroke work, and hydraulic power were calculated for all conditions. Multiple-linear regression analysis revealed a linear relation between E(a), R/T (where T is cycle length), and 1/C: E(a) = -0.13 + 1.02R/T + 0.31/C, indicating that R/T contributes about three times more to E(a) than arterial stiffness (1/C). It is demonstrated that different pathophysiological combinations of R and C may lead to the same E(a) and E(a)/E(max) but can result in differences of 10% in stroke work and 50% in maximal power.

Entities:  

Mesh:

Year:  2002        PMID: 11834502     DOI: 10.1152/ajpheart.00764.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

1.  Effect of exercise training on biologic vascular age in healthy seniors.

Authors:  Shigeki Shibata; Benjamin D Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

2.  Intra-aortic balloon pumping reduces the increased arterial load caused by acute cardiac depression, modifying central and peripheral load determinants in a time- and flow-related way.

Authors:  Daniel Bia; Edmundo I Cabrera-Fischer; Yanina Zócalo; Ricardo L Armentano
Journal:  Heart Vessels       Date:  2011-11-09       Impact factor: 2.037

3.  Use of the Frank-Starling mechanism during exercise is linked to exercise-induced changes in arterial load.

Authors:  Paul D Chantler; Vojtech Melenovsky; Steven P Schulman; Gary Gerstenblith; Lewis C Becker; Luigi Ferrucci; Jerome L Fleg; Edward G Lakatta; Samer S Najjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

4.  Computational Simulation of the Pulmonary Arteries and its Role in the Study of Pediatric Pulmonary Hypertension.

Authors:  Kendall S Hunter; Jeffrey A Feinstein; D Dunbar Ivy; Robin Shandas
Journal:  Prog Pediatr Cardiol       Date:  2010-12-01

Review 5.  The arterial Windkessel.

Authors:  Nico Westerhof; Jan-Willem Lankhaar; Berend E Westerhof
Journal:  Med Biol Eng Comput       Date:  2008-06-10       Impact factor: 2.602

6.  Impact of systemic hypertension on the assessment of aortic stenosis.

Authors:  L Kadem; J G Dumesnil; R Rieu; L-G Durand; D Garcia; P Pibarot
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 7.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-02-16       Impact factor: 4.132

8.  Ventricular-arterial coupling: Invasive and non-invasive assessment.

Authors:  Julio A Chirinos
Journal:  Artery Res       Date:  2013-03       Impact factor: 0.597

9.  Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility.

Authors:  Steffen Rex; Carlo Missant; Patrick Segers; Rolf Rossaint; Patrick F Wouters
Journal:  Intensive Care Med       Date:  2007-08-21       Impact factor: 17.440

10.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.